X-LINKED AGAMMAGLOBULINEMIA
Tracking # 20-812041
$99999.00
There are no ratings for this course
Learn moreCourse overview
X-LINKED AGAMMAGLOBULINEMIA OR XLA IS A PRIMARY IMMUNODEFICIENCY DISORDER THAT PREVENTS AFFECTED INDIVIDUALS FROM MAKING ANTIBODIES AND REQUIRES THEM TO RELY ON LIFELONG IMMUNOGLOBULIN REPLACEMENT THERAPY FOR SURVIVAL. WITHOUT IMMUNOGLOBULINS (OR ANTIBODIES), XLA PATIENTS ARE RENDERED VULNERABLE TO INVASIVE INFECTIONS. HOSPITALIZATION FOR BACTERIAL PNEUMONIA, REQUIRING INTRAVENOUS ANTIBIOTICS FOR RESOLUTION, IS USUALLY WHAT PROMPTS THE DIAGNOSTIC WORK-UP FOR PRIMARY IMMUNODEFICIENCY. THIS ACTIVITY REVIEWS THE PATHOPHYSIOLOGY OF XLA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN ITS MANAGEMENT.
Subject areas
This course counts toward the state boards and subject areas below.